{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T04:24:16Z","timestamp":1697516656823},"reference-count":37,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":724,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Biochemistry"],"published-print":{"date-parts":[[2000,1]]},"abstract":"<jats:p>Doxorubicin is among the most widely used anthracycline in cancer chemotherapy. In an attempt to avoid the cardiotoxicity and drug resistance of doxorubicin therapy, several analogues were synthesized. The cyanomorpholinyl derivative is the most cytotoxic. They differ greatly from their parent compound in their biological and pharmacological properties, inducing cross\u2010links in drug DNA complexes.<\/jats:p><jats:p>The present study concerns <jats:italic>N<\/jats:italic>\u2010cyanomethyl\u2010<jats:italic>N<\/jats:italic>\u2010(2\u2010methoxyethyl)\u2010daunomycin (CMDa), a synthetic analogue of cyanomorpholino\u2010daunomycin. Compared to doxorubicin, CMDa displays a cytotoxic activity on L1210 leukemia cells at higher concentration but is effective on doxorubicin resistant cells. The results of fluorescence quenching experiments as well as the melting temperature (\u0394<jats:italic>T<\/jats:italic><jats:sub>m<\/jats:sub>\u2003=\u20037.5\u2003\u00b0C) studies are consistent with a drug molecule which intercalates between the DNA base pairs and stabilizes the DNA double helix. The crystal structure of CMDa complexed to the hexanucleotide d(CGATCG) has been determined at 1.5\u2003\u00c5 resolution. The complex crystallizes in the space group P4<jats:sub>1<\/jats:sub>2<jats:sub>1<\/jats:sub>2 and is similar to other anthracycline\u2010hexanucleotide complexes. In the crystal state, the observed densities indicate the formation of <jats:italic>N<\/jats:italic>\u2010hydroxymethyl\u2010N\u2010(2\u2010methoxyethyl)\u2010daunomycin (HMDa) with the release of the cyano moiety without DNA alkylation. The formation of this degradation compound is discussed in relation with other drug modifications when binding to DNA. Comparison with two other drug\u2010DNA crystal structures suggests a correlation between a slight change in DNA conformation and the nature of the amino sugar substituents at the N3\u2032 position located in the minor groove.<\/jats:p>","DOI":"10.1046\/j.1432-1327.2000.01017.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T17:55:41Z","timestamp":1047405341000},"page":"457-464","source":"Crossref","is-referenced-by-count":3,"title":["Release of the cyano moiety in the crystal structure of <i>N<\/i>\u2010cyanomethyl\u2010<i>N<\/i>\u2010(2\u2010methoxyethyl)\u2010daunomycin complexed with d(CGATCG)"],"prefix":"10.1111","volume":"267","author":[{"given":"Pascale","family":"Saminadin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Dautant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Mondon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9atrice","family":"Langlois d\u2019Estaintot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Courseille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Pr\u00e9cigoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_6_2_2","volume-title":"Medicinal Chemistry 17.","author":"Arcamone F.","year":"1981"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1096-8652(199712)56:4<214::aid-ajh3>3.0.co;2-#"},{"key":"e_1_2_6_4_2","first-page":"101","volume-title":"Antibiotics","author":"DiMarco A.","year":"1974"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/newbio235017a0"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6093249"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi971272q"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.1985.10508434"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00478a006"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00070a014"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00462a016"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/20.14.3561"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/23.10.1710"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.1998.2580350.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.1995.10508824"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3495(92)81649-1"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00371a014"},{"key":"e_1_2_6_18_2","volume-title":"Preparation and Analysis of Protein Crystals","author":"McPherson A.","year":"1982"},{"key":"e_1_2_6_19_2","first-page":"465","article-title":"A highly efficient 24\u2010condition matrix for the crystallization of nucleic acid fragments.","volume":"52","author":"Berger I.","year":"1996","journal-title":"Acta Crystallogr."},{"key":"e_1_2_6_20_2","unstructured":"Reference withdrawn."},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1107\/S0021889893005588"},{"key":"e_1_2_6_22_2","first-page":"760","article-title":"The CCP4 suite: programs for protein crystallography.","volume":"50","author":"CCP","year":"1994","journal-title":"Acta Crystallogr."},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1107\/S0108767393007597"},{"key":"e_1_2_6_24_2","volume-title":"X\u2010PLOR Manual, Version 3.1: A System for X\u2010ray Crystallography and NMR.","author":"Br\u00fcnger A.T.","year":"1992"},{"key":"e_1_2_6_25_2","first-page":"C66","article-title":"Turbo\u2010Frodo: a new program for protein crystallography and modelling.","volume":"46","author":"Roussel A.","year":"1990","journal-title":"Acta Crystallogr."},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1107\/S0567740879004726"},{"key":"e_1_2_6_27_2","first-page":"57","article-title":"New parameters for the refinement of nucleic acid containing structure.","volume":"52","author":"Parkinson G.","year":"1996","journal-title":"Acta Crystallogr."},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/17.5.1797"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.1989.10507728"},{"key":"e_1_2_6_30_2","first-page":"215","volume-title":"Structure and Methods \u2013 DNA Protein Complexes and Proteins","author":"Lavery R.","year":"1990"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00160a047"},{"key":"e_1_2_6_32_2","first-page":"938","article-title":"Further addition to Molscript, Version 1.4, including reading and contouring of electron\u2010density maps.","volume":"55","author":"Esnouf R.M.","year":"1999","journal-title":"Acta Crystallogr."},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.11.4845"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00230a002"},{"key":"e_1_2_6_35_2","first-page":"69","article-title":"Base specific and regioselective chemical cross\u2010linking of daunorubicin to DNA.","volume":"204","author":"Leng F.","year":"1996","journal-title":"Eur. J. Biochem."},{"key":"e_1_2_6_36_2","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0021-9258(19)69754-1","article-title":"Binding of Saframycin A, a heterocyclic quinone anti\u2010tumor antibiotic to DNA as revealed by the use of the antibiotic labeled with [14C]tyrosine or [14C]cyanide.","volume":"256","author":"Ishiguro K.","year":"1981","journal-title":"J. Biol. Chem."},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00532a001"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00160a057"}],"container-title":["European Journal of Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1432-1327.2000.01017.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1432-1327.2000.01017.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T11:54:18Z","timestamp":1697457258000},"score":1,"resource":{"primary":{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/10.1046\/j.1432-1327.2000.01017.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["10.1046\/j.1432-1327.2000.01017.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1432-1327.2000.01017.x","archive":["Portico"],"relation":{},"ISSN":["0014-2956","1432-1033"],"issn-type":[{"value":"0014-2956","type":"print"},{"value":"1432-1033","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}